Oxford University scientist John Bell, who is leading one of the efforts to develop a coronavirus vaccine, said on NBC's "Meet the Press" Sunday that his research group will likely get evidence on whether the vaccine has efficacy by early June.

Why it matters: The world is pinning its hopes on a vaccine for COVID-19 to save lives, help us return to normal and emerge from an economic recession.

The big picture: Bell noted that the "efficacy of the vaccine in terms of generating strong antibody responses is probably going to be OK," but said that a big issue is ensuring safety.

  • "We're being very careful in the clinic to try to monitor exactly what's happening, but you know that doesn't mean there won't be safety signals because there may well be," he said. "And we'll be on the alert to see if we can see them."
  • Bell also added that while the coronavirus doesn't mutate at the pace of the flu, he suspects that this vaccine will likely have to be a seasonal one.

Go deeper: The race to make vaccines faster

Go deeper

Updated Oct 7, 2020 - Health

World coronavirus updates

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand now has active no coronavirus cases in the community after the final six people linked to the Auckland cluster recovered, the country's Health Ministry confirmed in an email Wednesday.

The big picture: The country's second outbreak won't officially be declared closed until there have been "no new cases for two incubation periods," the ministry said. Auckland will join the rest of NZ in enjoying no domestic restrictions from late Wednesday, Prime Minister Jacinda Ardern said, declaring that NZ had "beat the virus again."

Aug 10, 2020 - Health

The winter from hell

Photo: Stan Grossfeld/The Boston Globe via Getty Images

The hope and promise of May is gone, replaced by the realization that America is in for another miserable year of COVID-19.

Why it matters: Another winter — and another flu season — is on the way as the U.S. engages in a whack-a-mole strategy that slows down the virus in one region, but sees it flaring up in another.

State coronavirus testing plans fall short of demand

Data: Department of Health and Human Services via Harvard Global Health Institute; Note: New York City's plan is included in New York state; Cartogram: Andrew Witherspoon/Axios

The U.S. plans to test around 600,000 people for the coronavirus every day this month, according to plans that states submitted to the Department of Health and Human Services.

Yes, but: That's likely a drop in testing, compared to July, and it's not enough to meet national demand. By December, states said they plan to ramp up to around a collective 850,000 people tested a day — which also likely will not be enough.